Global /China /Healthcare /Drug Manufacturers - General /603858

Shandong Buchang Pharmaceuticals Co., Ltd.

603858

• SSE: 603858 • Delayed

16.28CNY -1.4%

2.40 USD

As of 23 June 2026, Shandong Buchang Pharmaceuticals Co., Ltd. has a market cap of $2.54B USD, ranking #6060 globally and #1369 in China. It ranks #481 in the Healthcare sector, and #190 in the Drug Manufacturers - General industry.

Global Rank

6060

Country Rank

1369

Sector Rank

481

Industry Rank

190

Key Stats

Market Cap

$2.54BUSD

17.17B CNY

Enterprise Value

$2.8BUSD

18.94B CNY

Revenue (TTM)

$1.62BUSD

10.96B CNY

EBITDA (TTM)

$210.7MUSD

1.43B CNY

Net Income (TTM)

$245.6KUSD

1.66M CNY

EBITDA Margin

13%

Profit Margin

PE Ratio

10326.3

PS Ratio

1.6

PB Ratio

1.7

EV/EBITDA

13.1

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Chao Zhao open_in_new

Employees

7,689

Founded

1993

Website

buchang.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.4%	0.5%	1.3%	-3.5%	-6.8%	5.6%	2.7%	-23%	-23%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	603858 山东步长制药股份有限公司 Class A ISIN: CNE100002FV6 Shares Out.: Shares Outstanding: 1.055B¹ Shares Float: 1.002B² TV: TradingView: SSE: 603858 SA: Stock Analysis: SHA: 603858 YF: Yahoo Finance: 603858.SS GF: Google Finance: SHA: 603858 BA: Barron's: 603858 MS: Morningstar: XSHG: 603858	16.28 CNY	TV: TradingView: SSE: 603858 SA: Stock Analysis: SHA: 603858 YF: Yahoo Finance: 603858.SS GF: Google Finance: SHA: 603858 BA: Barron's: 603858 MS: Morningstar: XSHG: 603858

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Shandong Buchang Pharmaceuticals Co., Ltd.

Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of medicines in China. It offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. The company was founded in 1993 and is based in Heze, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.9B 364.89B CNY 2K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.69B 336.36B CNY 2K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 1K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 641%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.53B 111.89B CNY 552%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 531%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 30K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 21K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 14K%	97.4	United States
Roche Holding AG SIX: RO	$318.49B 256.25B CHF 12K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$286.12B 215.59B GBP 11K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 11K%	15.1	United States

chevron_leftBack